2026/0159 - Invitation to Submit Proposals under Framework Agreements 961/2024 - Miscellaneous Medicines, 2025/1627 - Cardiovascular System Medicines, 900/2024 - Antiretroviral Medicines for the Treatment of HIV Infection, 899/2024 - Respiratory System Medicines, 780/2024 – Locomotor System Medicines, Used in the Treatment of Endocrine Diseases and Hormones, 491/2023 - Oncology and Immunomodulatory Medicines, 492/2023 - Anti-infective Medicines
About This Opportunity
TranslatedThis tender, identified as 2026/0159, is an invitation for proposals related to several framework agreements, primarily for the supply of medicines. The scope covers a diverse range of therapeutic areas. Specifically, it references framework agreements for 'Miscellaneous Medicines' (961/2024), 'Cardiovascular System Medicines' (2025/1627), 'Antiretroviral Medicines for the Treatment of HIV Infection' (900/2024), 'Respiratory System Medicines' (899/2024), 'Locomotor System Medicines' (including treatments for endocrine diseases and hormones, 780/2024), 'Oncology and Immunomodulatory Medicines' (491/2023), and 'Anti-infective Medicines' (492/2023). The invitation suggests that entities wishing to supply these categories of medicines should submit proposals under the relevant framework agreements. This approach streamlines the procurement process by leveraging pre-established agreements. The tender is likely aimed at ensuring the continued availability of essential medications for public health services or healthcare institutions throughout 2026. The framework agreements provide a basis for efficient contracting, potentially covering aspects like pricing, quality standards, and delivery terms for the specified pharmaceutical products.
This is a supplies contract in the health and medical services and information and communication technology sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1,310.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, identified by reference 2026/0159, is a call for proposals within Portugal for the supply of diverse medicinal products. It is being conducted under existing framework agreements, specifically referencing 961/2024 for "Medicamentos Diversos" (Diverse Medicines), 2025/1627 for "Medicamentos do aparelho cardiovascular" (Cardiovascular System Medicines), and 900/2024 for "Medicamentos antirret" (Antiretroviral Medicines). The contracting authority, operating through the Portal BASE which centralizes public contract information for mainland Portugal and its autonomous regions, is seeking qualified suppliers to fulfil these essential pharmaceutical needs.
Bidders are expected to demonstrate their capability to supply a range of pharmaceutical products as outlined within the specified framework agreements. Typical requirements for such procurements include a proven track record in the pharmaceutical supply chain, adherence to strict quality control and regulatory standards (such as Good Distribution Practice - GDP), and the capacity to ensure timely and reliable delivery across Portugal. Interested parties will need to submit detailed proposals addressing product availability, pricing structures, and logistical capabilities. Compliance with all national and European Union pharmaceutical regulations is paramount. Further specific details regarding the exact product lists, quantities, delivery schedules, and submission deadlines will be made available to registered bidders through the official tender documentation.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 13, 2026. Last refreshed 9 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde Tâmega e Sousa, E.P.E.
Unidade Local de Saúde Tâmega e Sousa, E.P.E. has issued 386 procurement notices on BidsFactory, including 2 currently open and 334 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde Tâmega e Sousa, E.P.E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €1,310. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to OVERPHARMA - PRODUTOS MEDICOS E FARM.. The award notice is archived on BidsFactory for transparency and market intelligence.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.